Home The present invention relates to the preparation of N-trityl-imidazole

The present invention relates to the preparation of N-trityl-imidazole

2019-12-18 14:09:48

The present invention relates to the preparation of N-trityl-imidazole and its salts and such compounds. More particularly, the present invention relates to N-trityl-imidazole and salts thereof of the formula: wherein R, R 1 and R 2 are hydrogen, lower alkyl or phenyl, or R 1 and R 2 together form a banded aromatic The benzene ring of the radical, X, X and X "are alkyl or electronegative moieties having 1 to 12 carbon atoms, and n, n and n" are integers of 0 to 2, or a pharmaceutically acceptable acid thereof salt. When R1, R2 or R3 is an alkyl moiety, those having 1 to 4 carbon atoms are preferred. When X, X or X "is an alkyl moiety, a moiety having 1 to 12 carbon atoms is preferred, and a moiety having 1 to 4 carbon atoms is particularly preferred. A particularly preferred electronegative substituent is halogen, ie, fluorine, chlorine , Bromine and iodine, NO CF CN, and S-lower alkyl and O-lower alkyl; preferably the alkyl portion has 1-4 carbon atoms, the term alkyl and lower alkyl also includes straight chain as branched alkyl Some also include those containing double bonds.

 

N-Trityl-imidazole salt (I) is a pharmaceutically acceptable non-toxic acid salt. Examples of suitable acids are hydrohalic acid (especially preferably hydrochloric acid), phosphoric acid, mono- and difunctional carboxylic acids such as acetic acid, propionic acid, maleic acid, succinic acid, fumaric acid, tartaric acid, citric acid, salicylic acid , Sorbic acid. Acid, lactic acid and 1, S-naphthalene-disulfonic acid. Hydrohalides, especially the hydrochloride, lactate and salicylate, are of particular value.

 

In a particularly preferred embodiment of the present invention, N-trityl-imidazole has the formula: wherein X, X 'and X "are alkyl or electronegative substituents having 1 to 12 carbon atoms, And n, n 'and n "are .1 or 2. With regard to formula IIa, particularly preferred substituents are those in which X "is fluorine, chlorine, bromine, iodine, NCFCN, SCHOCH and its" ". The compounds of the invention can be prepared according to techniques known per se, for example by Reacting a silver or alkali metal salt, especially a potassium salt of an imidazole of formula HI, with a trityl halide of formula IV: R, R and RX, X and X "and n, n" n "and" n " Has the above meaning, and Hal is chlorine, bromine or iodine in an inert solvent such as benzene, toluene, hexane, cyclohexane or diethyl ether at a temperature of about 1 ° C to about 110 ° C. Chem. 92, 92 (1959); 93, 570 (1960)].

 

The compounds of the invention can also be prepared according to techniques known per se by reacting an imidazole derivative of formula III with trityl methanol (see reaction of methanol corresponding to halide IV with a secondary amine). In this case, imidazole is usually used in excess of up to about 100%. If the method is carried out under pressure, a molar amount can be used. Furthermore, it may be advantageous to azeotropically remove water at the boiling point of the solvent used in the presence of a high boiling point inert organic solvent such as xylene, chlorobenzene, and the like. In the absence of a solvent, the process is performed in a temperature range of about 1 ° C to about 230 ° C, preferably about 170 ° C to about 190 ° C.

 

 

It may be more advantageous to promote water removal by working in the presence of a dehydrating agent such as magnesium sulfate. The number of moles of alkaline earth metal oxides (MgO, BaO, CaO) and Al is usually about 0, but it may be excessive to about 2-3 moles.

AA Blocks offers a comprehensive range of building blocks and specially designed scaffolds to support your R&D:

89-55-4

Diimidazo[1,5-a:1',5'-d]pyrazine-5,10-dione, DiHCl

Catalog No.:AA00157C

CAS No.:1215646-82-4 MDL No.:MFCD10699721

MF:C8H6Cl2N4O2 MW:261.0648

89-55-4

2,6-Bis[(2r,4s,5s)-1-benzyl-4,5-diphenylimidazolidin-2-yl]pyridine

Catalog No.:AA0016ZG

CAS No.:1223020-29-8 MDL No.:MFCD22581437

MF:C49H45N5 MW:703.9151

89-55-4

SKF-96365 hydrochloride

Catalog No.:AA000UFG

CAS No.:130495-35-1 MDL No.:MFCD00236407

MF:C22H27ClN2O3 MW:402.9144

89-55-4

Benzenesulfonamide, N-1H-benzimidazol-2-yl-

Catalog No.:AA000UQ8

CAS No.:13068-57-0 MDL No.:MFCD01350346

MF:C13H11N3O2S MW:273.3103

89-55-4

LY3023414

Catalog No.:AA0018X8

CAS No.:1386874-06-1 MDL No.:MFCD28411368

MF:C23H26N4O3 MW:406.4775

89-55-4

3H-Imidazo[2,1-i]purine

Catalog No.:AA0019EF

CAS No.:13875-63-3 MDL No.:MFCD00056763

MF:C7H5N5 MW:159.1481

89-55-4

4-Methyl-5-nitroimidazole

Catalog No.:AA001BVW

CAS No.:14003-66-8 MDL No.:MFCD01721395

MF:C4H5N3O2 MW:127.1014

89-55-4

(1H-Imidazol-1-yl)(2-methylfuran-3-yl)methanone

Catalog No.:AA001GH3

CAS No.:1415238-77-5 MDL No.:MFCD01795769

MF:C9H8N2O2 MW:176.1720

89-55-4

Phenol, 2-(1H-benzimidazol-2-yl)-4-methyl-

Catalog No.:AA001HZ7

CAS No.:14225-73-1 MDL No.:MFCD11180238

MF:C14H12N2O MW:224.2579

89-55-4

1-Ethyl-3-methylimidazolium methanesulfonate

Catalog No.:AA001KEL

CAS No.:145022-45-3 MDL No.:MFCD06798171

MF:C7H16N2O3S MW:208.2785

89-55-4

7,8-Dihydroimidazo[1,5-c]pyrimidin-5(6H)-one

Catalog No.:AA001KHK

CAS No.:14509-66-1 MDL No.:MFCD01443896

MF:C6H7N3O MW:137.1393

89-55-4

(S)-5-(1-(2,3-Dimethylphenyl)ethyl)-1h-imidazole hydrochloride

Catalog No.:AA001KI3

CAS No.:145108-58-3 MDL No.:MFCD07772269

MF:C13H17ClN2 MW:236.7405

89-55-4

2-Ethylsulfanyl-1h-benzoimidazole

Catalog No.:AA001DMR

CAS No.:14610-11-8 MDL No.:MFCD00223154

MF:C9H10N2S MW:178.2541

89-55-4

Imidazole hydrochloride

Catalog No.:AA001E5V

CAS No.:1467-16-9 MDL No.:MFCD00012695

MF:C3H5ClN2 MW:104.5382

89-55-4

4-(1H-imidazol-1-yl)piperidine

Catalog No.:AA001EHQ

CAS No.:147081-85-4 MDL No.:MFCD09834721

MF:C8H13N3 MW:151.2089

89-55-4

(6S)-6-phenyl-2H,3H,5H,6H-imidazo[2,1-b][1,3]thiazole

Catalog No.:AA001F0S

CAS No.:14769-73-4 MDL No.:MFCD00792481

MF:C11H12N2S MW:204.2914

89-55-4

1-Phenyl-1H-benzo[d]imidazol-2(3H)-one

Catalog No.:AA001FE7

CAS No.:14813-85-5 MDL No.:MFCD01658803

MF:C13H10N2O MW:210.2313

89-55-4

1H-Benzimidazole, 2-methyl-1-phenyl-

Catalog No.:AA001KTZ

CAS No.:1484-39-5 MDL No.:MFCD00227220

MF:C14H12N2 MW:208.2585

89-55-4

2,5-Diiodo-4-methyl-1H-imidazole

Catalog No.:AA001LPG

CAS No.:149510-85-0 MDL No.:MFCD02179520

MF:C4H4I2N2 MW:333.8969

89-55-4

5-Isopropyl-5-methylimidazolidine-2,4-dione

Catalog No.:AA001MCK

CAS No.:150226-22-5 MDL No.:MFCD00033554

MF:C7H12N2O2 MW:156.1824

89-55-4

1H-Benzimidazol-6-ol, 2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-

Catalog No.:AA001NDG

CAS No.:151602-49-2 MDL No.:MFCD08063681

MF:C16H17N3O3S MW:331.3895

89-55-4

4-(1H-Imidazol-2-yl)phenol

Catalog No.:AA001NVP

CAS No.:15548-89-7 MDL No.:MFCD08668843

MF:C9H8N2O MW:160.1726

89-55-4

(1-Hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-diyl)diphosphonic acid hydrate

Catalog No.:AA001O0N

CAS No.:155648-60-5 MDL No.:MFCD00890772

MF:C9H14N2O8P2 MW:340.1636

89-55-4

2-(1H-Imidazol-1-yl)pyridine-4-carbonitrile

Catalog No.:AA001PUL

CAS No.:158020-84-9 MDL No.:MFCD09929166

MF:C9H6N4 MW:170.1707

89-55-4

2-(1H-Imidazol-1-yl)benzoic acid

Catalog No.:AA001R3H

CAS No.:159589-67-0 MDL No.:MFCD06254507

MF:C10H8N2O2 MW:188.1827

89-55-4

1H-Benzimidazole, 6-methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1)

Catalog No.:AA001VT8

CAS No.:161796-77-6 MDL No.:MFCD23160332

MF:C17H19N3NaO3S MW:368.4058